斯洛伐克人群麻疹、腮腺炎和风疹特异性抗体血清流行率:一种疫苗,三种不同模式
2018年斯洛伐克横断面血清学调查分析4218名1-69岁人群,麻疹、腮腺炎、风疹IgG血清阳性率分别为91.7%、75.6%、95.9%。麻疹抗体随疫苗接种启动后明显下降,风疹抗体水平在首剂后每年下降10.7%、第二剂后每年下降3.5%。研究认为维持高水平两剂MMR疫苗接种覆盖率对预防暴发至关重要,持续血清监测有助于识别免疫空白人群。
要点
- 麻疹、腮腺炎、风疹总体血清阳性率分别为91.7%、75.6%、95.9%。
- 腮腺炎自然感染队列血清阳性率高于混合或单剂接种队列(OR分别为1.99和1.82)。
- 风疹抗体首剂后每年下降10.7%,第二剂后每年下降3.5%。
核心结论
- 维持高水平两剂MMR疫苗接种覆盖率对预防暴发至关重要,持续血清监测是识别和解决特定队列免疫空白、支持MMR消除工作的关键。
研究设计与样本
- 2018年开展的横断面血清学调查,分析4218名1-69岁斯洛伐克人群血样,采用特异性IgG检测确定抗体水平。
主要发现
- 总体血清阳性率麻疹91.7%、腮腺炎75.6%、风疹95.9%。
- 麻疹抗体水平在年龄最大队列中最高,疫苗接种启动后明显下降,接种队列血清阳性率显著低于假定自然感染队列。
- 腮腺炎血清阳性率明显低于麻疹和风疹;自然患病队列血清阳性率高于混合接种队列(OR=1.99)和单剂接种队列(OR=1.82)。
- 风疹所有年龄组总体血清阳性率很高,抗体水平在首剂后每年下降10.7%,第二剂后每年下降3.5%。
临床怎么用
- 研究结论认为维持高水平两剂MMR疫苗接种覆盖率对预防暴发至关重要。
- 研究结论认为持续血清监测对识别和解决特定队列免疫空白、支持MMR消除工作必不可少。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Measles, mumps, and rubella (MMR) rank among highly contagious diseases that present significant public health challenges despite availability of effective vaccines. In Slovakia, mass vaccination against these infections has historically maintained high coverage (over 95 %), although a gradual decline has been observed since around 2010 due to anti-vaccination activities. This trend creates concerning immunity gaps, risking disease resurgence. While vaccination has suppressed MMR in Slovakia, isolated outbreaks of measles and mumps have occurred, primarily in unvaccinated populations, unlike rubella, which has seen no significant epidemics since widespread vaccination. This study aimed to describe the seroprevalence of MMR antibodies in the Slovakian population, compare their immunological profiles, and identify potential risk groups. A cross-sectional serosurvey conducted in 2018 analyzed blood samples from 4218 individuals aged 1-69 years. Specific IgG tests determined respective antibody levels. Overall seropositivity rates were 91.7 % for measles, 75.6 % for mumps, and 95.9 % for rubella. For measles, antibody levels were highest in the oldest cohorts, with a clear decline observed after initiation of vaccination. Seropositivity was significantly lower in vaccinated cohorts compared to those with assumed natural infection. Mumps seropositivity was considerably lower than for measles and rubella. While mumps antibody trends were less pronounced, seropositivity in cohorts with natural disease overcoming was higher than in mixed or single-dose vaccinated cohorts (OR = 1.99 and 1.82 respectively). Rubella showed very high overall seropositivity across all age groups. Antibody levels for rubella also showed a sharp decline after the first dose (10.7 % per year) and a less pronounced decline after the second dose (3.5 % per year). The study concludes that maintaining high, two-dose MMR vaccination coverage is crucial for outbreak prevention. Continuous serosurveillance is essential to identify and address immunity gaps in specific cohorts, thereby supporting MMR elimination efforts.
引用
- Mikas J, Zibolenová J, Litvová S, et al. Seroprevalence of measles, mumps and rubella specific antibodies in the population of Slovakia: One vaccine, three different patterns. Vaccine. 2025. PMID: 41330190. doi:10.1016/j.vaccine.2025.128039
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。